TMCnet News
INSYS Therapeutics to Report Third Quarter 2017 Results on Nov. 2PHOENIX, Oct. 19, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today announced that it will release its third quarter 2017 financial results on Thursday, Nov. 2, before the U.S. financial markets open. Following the release of the financial results, Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will host a conference call at 8:30 a.m. Eastern Daylight Time. Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call available on the company’s website at https://www.insysrx.com/. Interested parties may also participate in the call by dialing (844) 263-8304 (from inside the U.S.) or (213) 358-0958 (from outside te U.S.). A webcasted replay of the conference call will be available a few hours after the event through the INVESTORS section, under the NEWS & EVENTS tab for “Presentations.” About INSYS SUBSYS® and SYNDROS® are trademarks of INSYS Development Company, Inc., a subsidiary of INSYS Therapeutics, Inc. NOTE: All trademarks and registered trademarks are the property of their respective owners. CONTACT: Media Relations Investor Relations |